- Home
- FFIN vs XENE Comparison
FFIN vs XENE Comparison
Compare FFIN & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FFIN | XENE |
|---|---|---|
| Founded | 1890 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.9B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FFIN | XENE |
|---|---|---|
| Price | $32.60 | $60.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | $36.50 | ★ $68.55 |
| AVG Volume (30 Days) | 592.3K | ★ 645.9K |
| Earning Date | 04-16-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.39% | N/A |
| EPS Growth | ★ 13.46 | N/A |
| EPS | ★ 1.00 | N/A |
| Revenue | N/A | ★ $311,000.00 |
| Revenue This Year | $17.16 | N/A |
| Revenue Next Year | $6.61 | $2,496.48 |
| P/E Ratio | $33.23 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.12 | $35.60 |
| 52 Week High | $37.83 | $72.66 |
Technical Indicators
Market Signals| Indicator | FFIN | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 31.20 | 42.23 |
| Support Level | $31.35 | $52.40 |
| Resistance Level | $32.98 | $62.91 |
| Average True Range (ATR) | 0.53 | 2.28 |
| MACD | -0.20 | -0.30 |
| Stochastic Oscillator | 0.94 | 9.03 |
Price Performance
Historical ComparisonAbout FFIN First Financial Bankshares Inc.
First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.